Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products
Wednesday, June 20, 2018Neptune Technologies Bioressources Inc today announced that it entered into a multiyear agreement with Canopy Growth Under the terms of the agreement Neptune will supplement Canopy Growths extraction refinement and extract product formulation capaci...
AcuraStem Receives Fast-Track SBIR Grant for the Development of a Novel Small Molecule Therapy to Treat ALS
Tuesday, June 19, 2018AcuraStem a fastgrowing innovative biotech company in Monrovia California has been awarded a million dollar Small Business Innovation Research FastTrack grant by the National Institute of Neurological Disorders and Stroke to continue research for th...
Clover Biopharmaceuticals Doses First Patient in Australia in Phase I Study of SCB-313 for Malignant Ascites
Tuesday, June 19, 2018Clover Biopharmaceuticals a biotechnology company focused on developing novel and transformative biologic therapies today announced that the first patient was dosed in a Phase I trial of SCB an investigational fullyhuman TRAILTrimer fusion protein fo...
Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache
Monday, June 18, 2018Teva Pharmaceutical Industries Ltd announced a change in the clinical development program of fremanezumab in chronic cluster headache The ENFORCE Phase III clinical development program includes a chronic cluster headache study an episodic cluster hea...
Celltrion Completes Resubmission to FDA for Proposed Trastuzumab Biosimilar
Monday, June 18, 2018Celltrion has made a resubmission to the FDA US Food and Drug Administration to obtain its marketing approval for CTP a proposed mAb biosimilar to Herceptin trastuzumab Celltrion submitted its abbreviated Biologics License Applications aBLAs for C...
Acerus Announces Approval of NATESTO® in South Korea
Friday, June 15, 2018Acerus Pharmaceuticals Corporation announced today that Hyundai Pharm Co Ltd Hyundai Acerus licensee reported that South Koreas Ministry of Food and Drug Safety MFDS has approved NATESTO for the treatment of hypogonadism Acerus is very pleased by...
Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab)
Friday, June 15, 2018Apexigen Inc and Yale Cancer Center announced a clinical trial collaboration to evaluate Apexigens APXM in combination with cabiralizumab and Opdivo in patients with advanced solid tumors The Phase clinical trial will evaluate the safety tolerabilit...
Pharmacolog AB and HelioMetrics® Partner to Provide Critcal Drug Diversion Solutions
Thursday, June 14, 2018Pharmacolog AB and HelioMetrics today announced a new partnership that will deliver solutions designed to stop drug diversion and provide safe administration of IV medications for hospitals and pharmacies in the United States Headquartered in Sweden...
Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217
Thursday, June 14, 2018Sage Therapeutics a clinicalstage biopharmaceutical company developing novel medicines to treat lifealtering central nervous system CNS disorders and Shionogi Co Ltd today announced they have entered into a strategic collaboration for the clinical d...
Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical
Wednesday, June 13, 2018Artelo Biosciences Inc a biopharmaceutical company focused on the development of therapeutic treatments that modulate the endocannabinoid system today announced that it has entered into a global research and development partnership with Syngene Inter...
